at vicarious surgical we are revolutionizing the field of surgical robotics. we seek to improve the lives of patients, enhance the ability of surgeons, and expand worldwide access to high-quality care through the use of surgical robotics. we have reimagined what is possible by building a human-like surgical robot and combining it with the world’s first virtual-reality surgical camera to allow surgeons to perform minimally-invasive surgery with the ease of an open procedure.
Company profile
Ticker
RBOT, RBOT-WT
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
Former names
D8 Holdings Corp.
SEC CIK
RBOT stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
4 Mar 24
8-K
Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results
4 Mar 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
8-K
Vicarious Surgical Strengthens Executive Team with Appointment of
29 Jan 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Vicarious Surgical Reports Third Quarter 2023 Financial Results
13 Nov 23
8-K
Vicarious Surgical Receives Continued Listing Standard Notice From NYSE
22 Sep 23
8-K
Vicarious Surgical Announces Launch of Proposed Public Offering
4 Aug 23
424B5
Prospectus supplement for primary offering
4 Aug 23
424B5
Prospectus supplement for primary offering
2 Aug 23
Transcripts
RBOT
Earnings call transcript
2023 Q4
4 Mar 24
RBOT
Earnings call transcript
2023 Q3
13 Nov 23
RBOT
Earnings call transcript
2023 Q2
27 Jul 23
RBOT
Earnings call transcript
2023 Q1
8 May 23
RBOT
Earnings call transcript
2022 Q4
13 Feb 23
RBOT
Earnings call transcript
2022 Q3
8 Nov 22
RBOT
Earnings call transcript
2022 Q2
8 Aug 22
RBOT
Earnings call transcript
2022 Q1
10 May 22
RBOT
Earnings call transcript
2021 Q4
4 Mar 22
RBOT
Earnings call transcript
2021 Q3
9 Nov 21
Latest ownership filings
4
Adam David Sachs
21 Mar 24
4
Sammy Khalifa
21 Mar 24
4
William John Kelly
21 Mar 24
144
Notice of proposed sale of securities
20 Mar 24
144
Notice of proposed sale of securities
20 Mar 24
144
Notice of proposed sale of securities
20 Mar 24
4
Adam David Sachs
5 Mar 24
4
Sammy Khalifa
5 Mar 24
4
William John Kelly
5 Mar 24
144
Notice of proposed sale of securities
4 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 60.05 mm | 60.05 mm | 60.05 mm | 60.05 mm | 60.05 mm | 60.05 mm |
Cash burn (monthly) | (no burn) | 5.64 mm | 7.12 mm | 7.53 mm | 5.76 mm | 5.78 mm |
Cash used (since last report) | n/a | 33.53 mm | 42.31 mm | 44.75 mm | 34.24 mm | 34.35 mm |
Cash remaining | n/a | 26.52 mm | 17.74 mm | 15.30 mm | 25.81 mm | 25.70 mm |
Runway (months of cash) | n/a | 4.7 | 2.5 | 2.0 | 4.5 | 4.4 |
Institutional ownership, Q2 2023
71.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 79 |
Opened positions | 9 |
Closed positions | 13 |
Increased positions | 28 |
Reduced positions | 11 |
13F shares | Current |
---|---|
Total value | 86.68 bn |
Total shares | 111.89 mm |
Total puts | 3.50 k |
Total calls | 44.80 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
VK Services | 23.32 mm | $42.69 bn |
Khosla Ventures V | 20.96 mm | $242.46 mm |
Innovation Endeavors III | 13.77 mm | $159.32 mm |
Gates Ventures | 10.10 mm | $116.81 mm |
Bright Insight | 6.17 mm | $21.11 mm |
Sun Hung Kai & Co | 5.44 mm | $0.00 |
Cadin | 5.08 mm | $19.06 mm |
BLK Blackrock | 3.84 mm | $7.03 bn |
MY.Alpha Management HK Advisors | 3.05 mm | $5.58 bn |
Chelvey International | 2.99 mm | $18.50 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Mar 24 | William John Kelly | Class A Common Stock | Sell | Dispose S | No | No | 0.339 | 1,290 | 437.31 | 517,841 |
20 Mar 24 | Adam David Sachs | Class A Common Stock | Sell | Dispose S | No | No | 0.3422 | 4,830 | 1.65 k | 1,730,220 |
20 Mar 24 | Sammy Khalifa | Class A Common Stock | Sell | Dispose S | No | No | 0.3407 | 3,863 | 1.32 k | 1,215,977 |
4 Mar 24 | Adam David Sachs | Class A Common Stock | Sell | Dispose S | No | No | 0.3712 | 16,040 | 5.95 k | 1,735,050 |
4 Mar 24 | Sammy Khalifa | Class A Common Stock | Sell | Dispose S | No | No | 0.371 | 8,273 | 3.07 k | 1,219,840 |
News
12 Health Care Stocks Moving In Friday's After-Market Session
22 Mar 24
12 Health Care Stocks Moving In Thursday's After-Market Session
21 Mar 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
6 Mar 24
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
5 Mar 24
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $1
5 Mar 24
Press releases
Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results
4 Mar 24
Thinking about buying stock in On Holding, Genco Shipping & Trading, Rio Tinto, Vicarious Surgical, or Plug Power?
28 Feb 24
Vicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
12 Feb 24